Estimating relative potency for receptor-mediated toxicity: Reevaluating the toxicity equivalence factor (TEF) model

Regulatory Toxicology and Pharmacology

Volumn 25, Issue 1, 1997, Pages 68-78

  Putzrath, Resha M ^a  

^a Georgetown Risk Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ENVIRONMENTAL CHEMICAL; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN; RECEPTOR;

ARTICLE; HUMAN; MODEL; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SPECIES DIFFERENCE; TOXICITY TESTING;

ERAGROSTIS TEF;

EID: 0031079625     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1996.1063     Document Type: Article

References (45)

1. Agency for Toxic Substances and Disease Registry (ATSDR) (1989). Toxicological Profile for 2,3,7,8-Tetrachlorodibenzo-p-di-oxin. ATSDR/TP-88/23. June.
2. Ahlborg, U. G., Becking, G. C., Birnbaum, L. S., Brouwer, A., Derks, H. J. G. M., Feeley, M., Golor, G., Hanberg, A., Larsen, J. C., Liem, A. K. D., Safe, S. H., Schlatter, C., Waern, F., Younes, M., and Yrjanheikki, E. (1994). Toxic equivalency factors for dioxin-like PCBs. Chemosphere 28, 1049-1067.
3. 6-cyclopentyladenosine and 8-cyclopentyltheophylline. Br. J. Pharmacol. 115, 1253-1259.
4. Barrett, J. C. (1995). Mechanisms for species differences in receptor-mediated carcinogenesis. Mutat. Res. 333, 189-202.
5. Birnbaum, L. S., and DeVito, M. J. (1995). Use of toxic equivalency factors for risk assessment for dioxins and related compounds. Toxicology 105, 391-402.
6. Birnbaum, L. S., Harris, M. W., Crawford, D. D., and Morrissey, R. E. (1987). Teratogenic effects of polychlorinated dibenzofurans in combination in C57BL/6N mice. Toxicol. Appl. Pharmacol. 91, 246-255.
7. Bradfield, C. A., and Poland, A. (1988). A competitive binding assay for 2,3,7,8-tetrachlorodibenzo-p-dioxin and related ligands of the Ah receptor. Mol. Pharmacol. 34, 682-688.
8. Clevenger, M. A., Putzrath, R. M., Ginevan, M. E., Brown, S. L., De-Rosa, C. M., and Muntaz, M. M. (1991). Risk assessment of mixtures: A model based on mechanisms of action and interaction. In Risk Analysis: Prospects and Opportunities (C. Zervos, K. Knox, L. Abramson, and R. Coppock, Eds.), pp. 293-303. Plenum Press, NY.
9. Crump, K. S. (1984). A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 4, 854-871.
10. DeVito, M. J., and Birnbaum, L. S. (1995). The importance of pharmacokinetics in determining the relative potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzofuran. Fundam. Appl. Toxicol. 24, 145-148.
11. DeVito, M. J., Ma, X., Babish, J. G., Menache, M., and Birnbaum, L. S. (1994). Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation. Toxicol. Appl. Pharmacol. 124, 82-90.
12. Environmental Protection Agency (EPA) (1996a). PCBs: Cancer Dose-Response Assessment and Application to Environmental Mixtures. Office of Research and Development. EPA/600/P-96/ 001A.
13. Environmental Protection Agency (EPA) (1996b). Proposed guidelines for carcinogen risk assessment. Fed. Reg. 61, 17960-18011.
14. Environmental Protection Agency (EPA) (1995). Proposed guidelines for neurotoxicity risk assessment; Notice. Fed. Reg. 60, 52032-52056.
15. Environmental Protection Agency (EPA) (1994). Health Assessment Document for 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds. External Review Draft. Office of Research and Development. EPA/600/BP-92/001b. June.
16. Environmental Protection Agency (EPA) (1991). Final guidelines for developmental toxicity risk assessment. Fed. Reg. 56, 63798-63826.
17. Environmental Protection Agency (EPA) (1989). Interim Procedures for Estimating Risks Associated with Exposures to Mixtures of Chlorinated Dibenzo-p-Dioxins and -Dibenzofurans (CDDs and CDFs) and 1989 Update. Risk Assessment Forum. EPA/625/3-89/ 016. March.
18. Environmental Protection Agency (EPA) (1985). Health Risk Assessment Approach for 2,3,7,8-Tetrachlorodibenzo-p-dioxin. Final Draft. Environmental Criteria and Assessment Office. ECAO-CIN-439. May.
19. Greco, W. R., Bravo, G., and Parsons, J. C. (1995). The search for synergy: A critical review from a response surface perspective. Pharmacol. Rev. 47, 331-385.
20. Haas, C. N., and Stirling, B. A. (1994). New quantitative approach for analysis of binary toxic mixtures. Environ. Toxicol. Chem. 13, 149-156.
21. Harris, M., Zacharewski, T., Piskorska-Pliszczynska, J., Rosengren, R., and Safe, S. (1990). Structure-dependent induction of aryl hydrocarbon hydroxylase activity in C57BL/6 mice by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related congeners: Mechanistic studies. Toxicol. Appl. Pharmacol. 105, 243-253.
22. ICF-Clement (1987). Comparative Potency Approach for Estimation of the Total Cancer Risk Associated with Exposures to Mixtures of Polycyclic Aromatic Hydrocarbons in the Environment. Final Report. ICF-Clement Associates, Washington, DC.
23. Johansson, N., Waern, F., Trossvik, C., Manzoor, E., Ahlborg, U. G., and Håkasson, H. (1995). Toxicological interactions between 2,3,7,8-TCDD, 1,2,3,7,8-PeCDD and 2,3,4,7,8-PeCDF in rat. In Organohalogen Compounds (L. Birnbaum, R. Clement, M. Fingerhut, F. Matsumura, S. Ramamoorthy, L. Robertson, and S. Safe, Eds.), Vol. 25, pp. 7-14. DIOXIN '95 Secretariat, P.O. Box 46060, Edmonton, Canada.
24. Kohn, M. C., and Portier, C. (1993). Effects of the mechanism of receptor-mediated gene expression on the shape of the dose-response curve. Risk Anal. 13, 565-572.
25. Lew, M. J. (1995). Extended concentration-response curves used to reflect full agonist efficacies and receptor occupancy-response coupling ranges. Br. J. Pharmacol. 115, 745-752.
26. Maronpot, R. R., Foley, J. F., Takahashi, K., Goldsworthy, T., Clark, G., Tritscher, A., Portier, C., and Lucier, G. (1993). Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: Histologic, biochemical, and cell proliferation endpoints. Environ. Health Perspect. 101, 634-642.
27. McGrath, L. F., Cooper, K. R., Georgopoulos, P., and Gallo, M. (1995). Alternative models for low dose-response analysis of biochemical and immunological endpoints for tetrachlorodibenzo-p-dioxin. Reg. Toxicol. Pharmacol. 21, 382-396.
28. Michaud, J. P., Gandolfi, A. J., and Brendel, K. (1994). Toxic responses to defined chemical mixtures: Mathematical models and experimental designs. Life Sci. 55, 635-651.
29. Parrott, J. L. (1993). Relative Potency of Polychlorinated Dibenzo-p-dioxins and Dibenzofurans for Inducing Mixed Function Oxygenases Activity in Rainbow Trout. Ph.D. Thesis, University of Waterloo, Ontario, Canada.
30. Parrott, J. L., Hodson, P. V., and Servos, M. R. (1995). Relative potency of polychlorinated dibenzo-p-dioxins and dibenzofurans for inducing mixed-function oxygenases activity in rainbow trout. Environ. Toxicol. Chem. 14, 1041-1050.
31. Putzrath, R. M., and Ginevan, M. E. (1994). Improving toxic equivalence factors (TEFs) for PCBs. In Superfund XV Conference Proceedings, Vol. 2, pp. 1457-1463. Hazardous Materials Control Resources Institute, Rockville, MD.
32. Rao, V. R., and Unger, A. (1995). A novel application of a competitive binding model in dioxin risk assessment. Reg. Toxicol. Pharmacol. 21, 108-116.
33. Rosengren, R., Safe, S., and Bunce, N. J. (1992). Kinetics of the association of several tritiated polychlorinated dibenzo-p-dioxin and dibenzofuran congeners with hepatic cytosolic Ah receptor from the Wistar rat. Chem. Res. Toxicol. 5, 376-382.
34. Safe, S. (1990). Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). CRC Crit. Rev. Toxicol 21, 51-88.
35. Schwartz, P. F., Gennings, C., and Chinchilli, V. M. (1995). Threshold models for combination data from reproductive and developmental experiments. J. Am. Stat. Assoc. 90, 862-870.
36. Solana, R. P., Chinchilli, V. M., Wilson, J. D., Carter, W. H., Jr., and Carchman, R. A. (1987). Evaluation of the interaction of three genotoxic agents in eliciting sister-chromatid exchanges using response surface methodology. Fundam. Appl. Toxicol. 9, 541-549.
37. Stephenson, R. P. (1956). A modification of receptor theory. Br. J. Pharmacol. 11, 379-393.
38. Svendsgaard, D. J., and Hertzberg, R. C. (1995). Statistical methods for the toxicological evaluation of the additivity assumption as used in the Environmental Protection Agency Chemical Mixture Risk Assessment Guidelines. In Toxicology of Chemical Mixtures (R. S. H. Yang, Ed.), pp. 599-642. Academic Press, New York.
39. Tallarida, R. J. (1995). Receptor discrimination and control of agonist-antagonist binding. Am. J. Physiol. 269, E379-E391.
40. Tallarida, R. J., Raffa, R. B., and McGonigle, P. (1988). Principles in General Pharmacology. Springer-Verlag, New York.
41. Taylor, P., and Insel, P. A. (1990). Molecular basis of pharmacologic selectivity. In Principles of Drug Action (W. B. Pratt and P. Taylor, Eds.), 3rd ed. Churchill Livingstone, NY.
42. Walker, M. K., Cook, P. M., Butterworth, B. C., Zabel, E. W., and Peterson, R. E. (1996). Potency of a complex mixture of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners compared to 2,3,7,8-tetrachlorodibenzo-p-dioxin in causing fish early life stage mortality. Fundam. Appl. Toxicol. 30, 178-186.
43. Wenke, M. (1971). Drug-receptor interactions. In Fundamentals of Biochemical Pharmacology (Z. M. Bacq, R. Čapek, R. Paoletti, and J. Renson, Eds.), pp. 367-410. Pergamon Press, New York.
44. Zabel, E. W., Walker, M. K., Hornung, M. W., Clayton, M. K., and Peterson, R. E. (1995). Interactions of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners for producing rainbow trout early life stage mortality. Toxicol. Appl. Pharmacol. 134, 204-213.
45. Zacharewski, T., Harris, M., and Safe, S. (1989). Induction of cytochrome P450-dependent monoxygenase activities in rat hepatoma H-4-IIE cells in culture by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds: Mechanistic studies using radiolabeled congeners. Arch. Biochem. Biophys. 272, 344-355.